Literature DB >> 8190299

The relationship between age and cognitive impairment in HIV-1 infection: findings from the Multicenter AIDS Cohort Study and a clinical cohort.

W G van Gorp1, E N Miller, T D Marcotte, W Dixon, D Paz, O Selnes, J Wesch, J T Becker, C H Hinkin, M Mitrushina.   

Abstract

Previous studies have identified age as a risk factor for many neurologic disorders, and a "cerebral reserve" factor has been postulated to explain these findings. This study examined whether age represents a risk factor for HIV-1-related neuropsychological dysfunction. Subjects for study 1 were primarily asymptomatic seropositive (n = 1,066) and seronegative (n = 1,004) nonelderly male community volunteers who completed neuropsychological and reaction time measures. Data analyses revealed a significant effect for age on reaction time and timed neuropsychological measures, but no interaction between age and serostatus. Study 2, employing a similar neuropsychological battery, consisted of 76 seropositive men (29 over age 55) recruited from community outpatient clinics and 47 seronegative controls. We found serostatus and age to have main effects on a number of measures, but a trend for an effect of age-serostatus interaction on only one measure.

Entities:  

Mesh:

Year:  1994        PMID: 8190299     DOI: 10.1212/wnl.44.5.929

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

Review 1.  The neuropsychology of HIV/AIDS in older adults.

Authors:  David J Hardy; David E Vance
Journal:  Neuropsychol Rev       Date:  2009-02-27       Impact factor: 7.444

2.  Extrapyramidal motor signs in older adults with HIV disease: frequency, 1-year course, and associations with activities of daily living and quality of life.

Authors:  Savanna M Tierney; Steven Paul Woods; David Sheppard; Ronald J Ellis
Journal:  J Neurovirol       Date:  2018-12-10       Impact factor: 2.643

Review 3.  Neurocognitive impact of antiretroviral treatment: thinking long-term.

Authors:  Megan E McPhail; Kevin R Robertson
Journal:  Curr HIV/AIDS Rep       Date:  2011-12       Impact factor: 5.071

4.  The current understanding of overlap between characteristics of HIV-associated neurocognitive disorders and Alzheimer's disease.

Authors:  Leah H Rubin; Erin E Sundermann; David J Moore
Journal:  J Neurovirol       Date:  2019-01-22       Impact factor: 2.643

Review 5.  Aging and Neurocognitive Functioning in HIV-Infected Women: a Review of the Literature Involving the Women's Interagency HIV Study.

Authors:  David E Vance; Leah H Rubin; Victor Valcour; Drenna Waldrop-Valverde; Pauline M Maki
Journal:  Curr HIV/AIDS Rep       Date:  2016-12       Impact factor: 5.071

Review 6.  HIV and aging: effects on the central nervous system.

Authors:  Silvia Cañizares; Mariana Cherner; Ronald J Ellis
Journal:  Semin Neurol       Date:  2014-04-08       Impact factor: 3.420

7.  Effect of age and level of education on neurocognitive impairment in HIV positive Zambian adults.

Authors:  Norma Kabuba; J Anitha Menon; Donald R Franklin; Stian Lydersen; Robert K Heaton; Knut A Hestad
Journal:  Neuropsychology       Date:  2018-03-05       Impact factor: 3.295

Review 8.  Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms.

Authors:  Victor G Valcour; Cecilia M Shikuma; Michael R Watters; Ned C Sacktor
Journal:  AIDS       Date:  2004-01-01       Impact factor: 4.177

9.  1H MR spectroscopy of the brain in HIV-1-seropositive subjects: evidence for diffuse metabolic abnormalities.

Authors:  C D Marcus; S D Taylor-Robinson; J Sargentoni; J G Ainsworth; G Frize; P J Easterbrook; S Shaunak; D J Bryant
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

10.  Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia.

Authors:  Malcolm J Avison; Avindra Nath; Robin Greene-Avison; Frederick A Schmitt; Rodney A Bales; As'ad Ethisham; Richard N Greenberg; Joseph R Berger
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.